Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2026)

Amneal Pharmaceuticals has reported Goodwill & Intangibles for 10 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles fell 5.26% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 5.26% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 12.85% from the prior year.
• Goodwill & Intangibles was $1.2 billion for Q2 2026 at Amneal Pharmaceuticals, up from $1.1 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.8 billion in Q1 2022, with the low at $1.1 billion in Q1 2026.
• Average Goodwill & Intangibles over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles climbed 1.51% in 2022, then dropped 14.12% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $1.7 billion in 2022, then slipped by 12.15% to $1.5 billion in 2023, then declined by 10.69% to $1.3 billion in 2024, then decreased by 12.85% to $1.2 billion in 2025, then increased by 1.93% to $1.2 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.